Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome (ARDS)
Admission
approach
ARDS
arterial
association
Biomarker
Clinical course
Clinical outcome
Comorbidity
Concentration
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
Critically ill patient
described
diagnostic
evaluate
Factor
hallmark
high risk
Horowitz Quotient
hypertension
ICU
ICU treatment
identify
Ill
IMPROVE
Increased
inhibitory
intensive care
Macrophage Migration Inhibitory Factor (MIF)
management
mechanically ventilated
MIF
Migration
Organ failure
organ function
outcome
Patient
Perspective
pharmacological treatment
Predictive
predominant
Prospective
prospective observational study
severe COVID-19 disease
Severe COVID-19 Infection
significantly
significantly lower
SOFA
SOFA score
survival
syndrome
Treatment strategies
were measured
[DOI] 10.3390/diagnostics11020332 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/diagnostics11020332 PMC 바로가기 [Article Type] Article